Szczegóły publikacji

Opis bibliograficzny

Chronic but not acute antidepressant treatment alters serum zinc/copper ratio under pathological/zinc-deficient conditions in mice / K. Młyniec, B. OSTACHOWICZ, A. KRAKOWSKA, W. RECZYŃSKI, W. Opoka, G. Nowak // Journal of Physiology and Pharmacology ; ISSN 0867-5910. — 2014 — vol. 65 no. 5, s. 673–678. — Bibliogr. s. 677–678. — K. Młyniec - afiliacja: Jagiellonian University Medical College

Autorzy (6)

Słowa kluczowe

zinc copper ratioproinflammatory cytokinescopperzinc deficiencyserumdepressionoxidative stressantidepressant

Dane bibliometryczne

ID BaDAP85949
Data dodania do BaDAP2014-11-28
Rok publikacji2014
Typ publikacjiartykuł w czasopiśmie
Otwarty dostęptak
Czasopismo/seriaJournal of Physiology and Pharmacology

Abstract

Depression is the leading psychiatric disorder with a high risk of morbidity and mortality. Clinical studies report lower serum zinc in depressed patients, suggesting a strong link between zinc and mood disorders. Also copper as an antagonistic element to zinc seems to play a role in depression, where elevated concentration is observed. In the present study we investigated serum copper and zinc concentration after acute or chronic antidepressant (AD) treatment under pathological/zinc-deficient conditions. Zinc deficiency in mice was induced by a special diet administered for 6 weeks (zinc adequate diet – ZnA, contains 33.5 mgZn/kg; zinc deficient diet – ZnD, contains 0.2 mgZn/kg). Animals received acute or chronically saline (control), imipramine, escitalopram, reboxetine or bupropion. To evaluate changes in serum copper and zinc concentrations the total reflection X-ray fluorescence (TXRF) and flame atomic absorption spectrometry (FAAS) was performed. In ZnD animals serum zinc level was reduced after acute ADs treatment (similarly to vehicle treatment), however, as demonstrated in the previous study after chronic ADs administration no differences between both ZnA and ZnD groups were observed. Acute ADs in ZnD animals caused different changes in serum copper concentration with no changes after chronic ADs treatment. The calculated serum Zn/Cu ratio is reduced in ZnD animals (compared to ZnA subjects) treated with saline (acutely or chronically) and in animals treated acutely with ADs. However, chronic treatment with ADs normalized (by escitalopram, reboxetine or bupropion) or increased (by imipramine) this Zn/Cu ratio. Observed in this study normalization of serum Zn/Cu ratio in depression-like conditions by chronic (but not acute) antidepressants suggest that this ratio may be consider as a marker of depression or treatment efficacy. © 2014, Polish Physiological Society. All rights reserved.

Publikacje, które mogą Cię zainteresować

artykuł
#41257Data dodania: 4.11.2008
Intraperitoneal zinc administration increases extracellular zinc in the rat prefrontal cortex / W. Opoka, M. Sowa-Kućma, M. Kowalska, B. BAŚ, K. Gołębiowska, G. Nowak // Journal of Physiology and Pharmacology ; ISSN 0867-5910. — 2008 — vol. 59 no. 3, s. 477–487. — Bibliogr. s. 485–487
artykuł
#95159Data dodania: 28.1.2016
Decreased serum zinc concentration during depressive episode in patients with bipolar disorder / Marcin Siwek, Magdalena Sowa-Kućma, Krzysztof Styczeń, Bernadeta Szewczyk, Witold RECZYŃSKI, Paulina Misztak, Roman Topór-Mądry, Gabriel Nowak, Dominika Dudek, Janusz K. Rybakowski // Journal of Affective Disorders ; ISSN 0165-0327. — 2016 — vol. 190, s. 272–277. — Bibliogr. s. 276–277, Abstr. — Publikacja dostępna online od: 2015-12-27. — Witold Reczyński – afiliacja: University of Science and Technology